Market Overview:
The global telmisartan tablet market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hypertension and rising awareness about the benefits of telmisartan tablets. By type, the global telmisartan tablet market is segmented into 20mg/pill, 40mg/pill, and 80mg/pill segments. The 40mg/pill segment is expected to account for the largest share of the global telmisartan tablet market in 2018. By application, the global telmisartan tablet market is segmented into hospital, special clinic, and recovery center segments.
Product Definition:
Telmisartan Tablet is used for the treatment of high blood pressure and heart failure.
20mg/pill:
20mg/pill is the average daily dose of telmisartan tablets. It is used to treat hypertension and to lower the risk of cardiovascular diseases. The global market for 20mg/pill is expected to witness significant growth over the forecast period owing to its cost-effectiveness, easy availability, high patient compliance, minimal side effects and presence of insurance coverage in major economies such as U.S., Canada, Germany etc.
40mg/pill:
40mg/pill is used to treat high blood pressure and heart failure. It also helps in reducing the risk of stroke and kidney problems. Telmisartan 40 mg tablet is a form of angiotensin II receptor blocker (ARB). Angiotensin II receptor blockers are used to treat hypertension, congestive heart failure, cardiac arrhythmia, and edema.
Application Insights:
The hospital application segment led the global telmisartan tablet market in 2017. The high usage rates of these tablets in hospitals are expected to be a major factor driving the segment growth over the forecast period. Moreover, increasing awareness about cardiovascular diseases and growing aging population is further anticipated to drive demand for hospital applications over the forecast period.
Special clinics accounted for a significant share of revenue in 2017 owing to rising awareness about cardiovascular diseases and growing aging population across various regions including North America, Europe and Asia Pacific. In addition, manufacturers are entering into new clinical partnerships with specialty clinics which is further anticipated to fuel industry expansion over the next eight years till 2030.
Regional Analysis:
North America was the largest regional market in 2017 owing to high consumer awareness and availability of a wide range of products. The region is expected to maintain its dominance over the forecast period due to increasing demand for generic drugs coupled with growing geriatric population. Asia Pacific is anticipated to be the fastest-growing region during the forecast years on account of rising disposable income, improving healthcare infrastructure, and expanding patient pool in emerging economies including China and India. Moreover, expansion of distribution network by Cipla will help increase product availability across this region over the coming years.
The MEA market has been experiencing strong growth since 2010s on account of rapid economic development along with increased disposable income among consumers as well as patients suffering from hypertension or diabetes.
Growth Factors:
- Increasing prevalence of hypertension and other cardiovascular diseases: The global prevalence of hypertension is estimated to be around 25%. This number is expected to grow significantly in the next few years due to increasing obesity rates, aging population, and changing lifestyles. This will create a large pool of patients who will require treatment, thereby driving the demand for telmisartan tablets.
- Growing awareness about the benefits of telmisartan therapy: There is growing awareness among physicians and patients about the benefits of telmisartan therapy for treating hypertension and other cardiovascular diseases. This is likely to lead to an increase in demand for telmisartan tablets in the coming years.
- Availability of generic versions: The availability of generic versions of telmisartan tablets has helped reduce their cost, making them more affordable for patients worldwide. This is likely to boost demand for these drugs in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Telmisartan Tablet Market Research Report
By Type
20mg/pill, 40mg/pill, 80mg/pill
By Application
Hospital, Special Clinic, Recovery Center
By Companies
Boehringer Ingelheim, Glenmark, Hikma, Solco Healthcare, Torrent, Zydus, Alembic, Amneal Pharmaceuticals, Aurobindo, Cadista, Sandoz, Camber Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Telmisartan Tablet Market Report Segments:
The global Telmisartan Tablet market is segmented on the basis of:
Types
20mg/pill, 40mg/pill, 80mg/pill
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Special Clinic, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Glenmark
- Hikma
- Solco Healthcare
- Torrent
- Zydus
- Alembic
- Amneal Pharmaceuticals
- Aurobindo
- Cadista
- Sandoz
- Camber Pharmaceuticals
Highlights of The Telmisartan Tablet Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 20mg/pill
- 40mg/pill
- 80mg/pill
- By Application:
- Hospital
- Special Clinic
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Telmisartan Tablet Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Telmisartan tablet is a medication used to treat high blood pressure. It works by reducing the amount of blood that flows through your veins. This can help to lower your blood pressure. Telmisartan tablet is also known as telmizumab, and it comes in the form of a pill or injection.
Some of the major companies in the telmisartan tablet market are Boehringer Ingelheim, Glenmark, Hikma, Solco Healthcare, Torrent, Zydus, Alembic, Amneal Pharmaceuticals, Aurobindo, Cadista, Sandoz, Camber Pharmaceuticals.
The telmisartan tablet market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Telmisartan Tablet Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Telmisartan Tablet Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Telmisartan Tablet Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Telmisartan Tablet Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Telmisartan Tablet Market Size & Forecast, 2020-2028
4.5.1 Telmisartan Tablet Market Size and Y-o-Y Growth
4.5.2 Telmisartan Tablet Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 20mg/pill
5.2.2 40mg/pill
5.2.3 80mg/pill
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Special Clinic
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Telmisartan Tablet Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Telmisartan Tablet Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 20mg/pill
9.6.2 40mg/pill
9.6.3 80mg/pill
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Special Clinic
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 20mg/pill
10.6.2 40mg/pill
10.6.3 80mg/pill
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Special Clinic
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 20mg/pill
11.6.2 40mg/pill
11.6.3 80mg/pill
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Special Clinic
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 20mg/pill
12.6.2 40mg/pill
12.6.3 80mg/pill
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Special Clinic
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 20mg/pill
13.6.2 40mg/pill
13.6.3 80mg/pill
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Special Clinic
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Telmisartan Tablet Market: Competitive Dashboard
14.2 Global Telmisartan Tablet Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim
14.3.2 Glenmark
14.3.3 Hikma
14.3.4 Solco Healthcare
14.3.5 Torrent
14.3.6 Zydus
14.3.7 Alembic
14.3.8 Amneal Pharmaceuticals
14.3.9 Aurobindo
14.3.10 Cadista
14.3.11 Sandoz
14.3.12 Camber Pharmaceuticals
